21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Biofilm formation - what we can learn from recent developments

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="P1">Bjarnsholt T, Buhlin K, Dufrenê YF, Gomelsky M, Moroni A, Ramstedt M, Rumbaugh KP, Schulte T, Sun L, Åkerlund B, Römling U (University of Copenhagen; Copenhagen University Hospital, Copenhagen, Denmark; Karolinska Institutet, Huddinge, Sweden; Université catholique de Louvain, Louvain-la-Neuve, Belgium; University of Wyoming, Laramie, Wyoming, USA; Universitá degli Studi di Milano, Milano, Italy; Umeå University, Umeå, Sweden; Texas Tech University Health Sciences Center, Lubbock, Texas, USA; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden). Biofilm formation – what we can learn from recent developments. </p><p id="P2">Although biofilms have been observed early in the history of microbial research, their impact has only recently been fully recognized. Biofilm infections, which contribute to up to 80% of human microbial infections, are associated with common human disorders, such as diabetes mellitus and poor dental hygiene, but also with medical implants. The associated chronic infections such as wound infections, dental caries and periodontitis significantly enhance morbidity, affect quality of life and can aid development of follow-up diseases such as cancer. Biofilm infections remain challenging to treat and antibiotic monotherapy is often insufficient, although some rediscovered traditional compounds have shown surprising efficiency. Innovative anti-biofilm strategies include application of anti-biofilm small molecules, intrinsic or external stimulation of production of reactive molecules, utilization of materials with antimicrobial properties and dispersion of biofilms by digestion of the extracellular matrix, also in combination with physical biofilm breakdown. Although basic principles of biofilm formation have been deciphered, the molecular understanding of the formation and structural organization of various types of biofilms has just begun to emerge. Basic studies of biofilm physiology have also resulted in an unexpected discovery of cyclic dinucleotide second messengers that are involved in interkingdom crosstalk via specific mammalian receptors. These findings even open up new venues for exploring novel anti-biofilm strategies. </p>

          Related collections

          Most cited references106

          • Record: found
          • Abstract: found
          • Article: not found

          The biofilm matrix.

          The microorganisms in biofilms live in a self-produced matrix of hydrated extracellular polymeric substances (EPS) that form their immediate environment. EPS are mainly polysaccharides, proteins, nucleic acids and lipids; they provide the mechanical stability of biofilms, mediate their adhesion to surfaces and form a cohesive, three-dimensional polymer network that interconnects and transiently immobilizes biofilm cells. In addition, the biofilm matrix acts as an external digestive system by keeping extracellular enzymes close to the cells, enabling them to metabolize dissolved, colloidal and solid biopolymers. Here we describe the functions, properties and constituents of the EPS matrix that make biofilms the most successful forms of life on earth.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health

            The colon is inhabited by a dense population of microorganisms, the so-called “gut microbiota,” able to ferment carbohydrates and proteins that escape absorption in the small intestine during digestion. This microbiota produces a wide range of metabolites, including short chain fatty acids (SCFA). These compounds are absorbed in the large bowel and are defined as 1-6 carbon volatile fatty acids which can present straight or branched-chain conformation. Their production is influenced by the pattern of food intake and diet-mediated changes in the gut microbiota. SCFA have distinct physiological effects: they contribute to shaping the gut environment, influence the physiology of the colon, they can be used as energy sources by host cells and the intestinal microbiota and they also participate in different host-signaling mechanisms. We summarize the current knowledge about the production of SCFA, including bacterial cross-feedings interactions, and the biological properties of these metabolites with impact on the human health.
              • Record: found
              • Abstract: found
              • Article: not found

              Microbial complexes in subgingival plaque

              Journal of Clinical Periodontology, 25(2), 134-144

                Author and article information

                Journal
                Journal of Internal Medicine
                J Intern Med
                Wiley
                09546820
                October 2018
                October 2018
                July 09 2018
                : 284
                : 4
                : 332-345
                Affiliations
                [1 ]Department of Immunology and Microbiology; Costerton Biofilm Centre; University of Copenhagen; Copenhagen Denmark
                [2 ]Department of Clinical Microbiology; Copenhagen University Hospital; Copenhagen Denmark
                [3 ]Department of Dental Medicine; Division of Oral Facial Diagnostics and Surgery; Karolinska Institutet; Huddinge Sweden
                [4 ]Institute of Life Sciences; Université catholique de Louvain; Louvain-la-Neuve Belgium
                [5 ]Department of Molecular Biology; University of Wyoming; Laramie WY USA
                [6 ]Department of Biology and CNR-Istituto di Biofisica; Università degli Studi di Milano; Milano Italy
                [7 ]Department of Chemistry; Umeå University; Umeå Sweden
                [8 ]Departments of Surgery & Immunology & Molecular Microbiology; Texas Tech University Health Sciences Center; Lubbock TX USA
                [9 ]Department of Medicine Solna; Science for Life Laboratory; Karolinska Institutet; Stockholm Sweden
                [10 ]Department of Infectious Diseases; Karolinska University Hospital; Stockholm Sweden
                [11 ]Department of Microbiology, Tumor and Cell Biology; Karolinska Institutet; Stockholm Sweden
                [12 ]Department of Medicine Huddinge; Unit of Infectious Diseases; Karolinska University Hospital; Stockholm Sweden
                Article
                10.1111/joim.12782
                6927207
                29856510
                ddbd2a43-9ed2-4072-ab41-57a42ceba034
                © 2018

                http://doi.wiley.com/10.1002/tdm_license_1.1

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                History

                Comments

                Comment on this article

                Related Documents Log